Thirty-six percent of high-school seniors have used cannabis in the past year, and an
alarming 6.5% smoked cannabis daily, up from 2.4% in 1993. Adolescents and emerging …

Although cannabis use is associated with an increased risk of developing psychosis, the
cannabis constituent cannabidiol (CBD) may have antipsychotic properties. This review …

We conducted a systematic review to assess the evidence for specific effects of cannabis on
impulsivity, disinhibition and motor control. The review had a specific focus on neuroimaging …

Background: In recent years, growing concerns about the effects of cannabis use on mental
health have renewed interest in cannabis research. In particular, there has been a marked …

Accumulating evidence suggests involvement of the endocannabinoid system in the
pathophysiology of schizophrenia, which signifies a potential application for this system in …

Clinical and neurobiological findings suggest that the cannabinoids and the
endocannabinoid system may be implicated in the pathophysiology and treatment of …

Epidemiological studies have shown that the association between cannabis and psychosis
is robust and consistent across different samples, with compelling evidence for a dose …

The confirmation of Δ9-tetrahydrocannabinol (THC) in oral fluid (OF) is an important issue for
assessing Driving Under the Influence of Drugs (DUID). The aim of this research was to …

Neuroimaging, including PET, MRI, and MRS, is a powerful approach to the study of brain
function. This article reviews neuroimaging findings related to alcohol and other drugs of …

JWH-018 (1-pentile-3-(1-naftoil) indolo) è un agonista cannabinoide sintetico
commercializzatoillegalmente per i suoi effetti psicoattivi simili a quelli prodotti dalla …